Basics
Description
- Tuberculosis (TB) is an infectious disease with protean manifestations, causing significant global morbidity and mortality.
Mechanism
- Infectious droplet nuclei are inhaled through the respiratory tract.
- Bacteria are dispersed through coughing, sneezing, speaking, singing.
- Primary TB/latent TB infection (LTBI):
- Initial infection occurs when organisms enter the alveoli, become engulfed by macrophages, and spread via regional lymph nodes to the bloodstream.
- Patients are usually asymptomatic.
- May be progressive/fatal in immunocompromised hosts.
- Positive reaction to purified protein derivative (PPD) indicates past exposure or infection.
- Negative PPD does not rule out active TB.
- May progress to active TB (5 " “10%).
- Reactivation TB:
- LTBI becomes active TB.
- Systemic (15%) and pulmonary (85%) symptoms.
- TB affects about one-third of the worlds population (90 million new cases in the past decade worldwide, with about 30 million deaths).
- Centers for Disease Control and Prevention (CDC) statistics from 2011 show TB in US at an all-time low.
- TB rates in US have continued to decline since 1993.
- Increase in US foreign-born cases
- Still an estimated 10 " “15 million people are infected in US alone.
Etiology
- Infection with Mycobacterium tuberculosis, a slow-growing, aerobic, acid-fast bacillus resulting in disease.
- Humans are the only known reservoir.
- Recent TB epidemics:
- HIV-infected patients
- Multidrug-resistant TB (MDR-TB)
- Extensively drug-resistant TB (XDR-TB):
- High mortality, few effective drugs
Diagnosis
Signs and Symptoms
- Depending upon site of infection; all human tissues have potential for infection.
- Pulmonary TB:
- Cough
- Fever, night sweats
- Malaise, weight loss
- Hemoptysis
- Pleuritic chest pain
- Shortness of breath
- Extrapulmonary TB:
- CNS infections:
- Meningismus
- Cranial nerve defects, diplopia
- Headache, fever, malaise
- Confusion
- Acute ischemic stroke
- Pericarditis:
- Pleuritic chest pain increased with recumbency
- Renal infection:
- Spinal TB (Potts disease):
- Back pain/stiffness, point tenderness
- Fever
- Decreased range of motion
- Cervical lymphadenitis (scrofula):
- Unilateral, painless
- May form draining sinus tracts
- Miliary TB:
- Multiorgan system involvement
- Diffuse adenopathy
- Hepatomegaly
- Splenomegaly
- Weight loss, fever
History
Predisposing factors and conditions for TB: ‚
- HIV infection and other immunocompromised states (organ transplant, renal failure, diabetes)
- Drug and alcohol abuse
- Poverty, homelessness (living in shelters)
- Institutionalization (nursing homes, prisons)
- Immigration from an endemic area
- Positive PPD test/previous infection
Physical Exam
- Fever
- Tachycardia
- Hypoxia
- Cachexia
- Abnormal breath sounds
- Cervical lymphadenopathy
Essential Workup
- Diagnosis difficult due to the variety of clinical presentations.
- Chest radiography:
- Most valuable test for active pulmonary TB
- Skin testing: PPD
Diagnosis Tests & Interpretation
Lab
- CBC
- Electrolytes, BUN, creatinine, glucose, LFTs
- Hyponatremia (due to syndrome of inappropriate antidiuretic hormone)
- ABGs for oxygenation/ventilation assessment
- Sputum staining for acid-fast bacilli (Ziehl " “Neelsen stain):
- Provides a quick presumptive diagnosis
- Sputum, CSF, blood, urine, or peritoneal fluid culture:
- Gold standard for diagnosis of TB
- Average time for positive culture is 3 " “6 wk.
- DNA polymerase chain reaction (PCR) testing more rapid
- Lumbar puncture with CSF analysis:
- For suspected TB meningitis
- Elevated WBCs with lymphocyte predominance
- Elevated protein
- Low to normal glucose
Imaging
- Chest radiograph:
- May be normal
- In primary disease, parenchymal infiltrates with unilateral hilar adenopathy are the classic findings.
- Reactivation TB typically appears as cavitary lesions with or without calcification, usually in upper lung segments.
- Miliary TB shows bilateral disseminated 2-mm nodules throughout lungs.
- Chest radiograph may be nondefinitive in AIDS/immunocompromised patients.
- Unilateral pleural effusion in both primary and reactivation TB
- Tracheal deviation with scarring or atelectasis
- Ghon focus " ”calcified scar/healed primary focus of infection
- Ghon complex " ”primary infiltrate with associated unilateral hilar adenopathy
- Spine radiographs for Potts disease:
- May be normal
- Anterior wedging of 2 involved vertebral bodies and destruction of disk
- CT chest:
- Better defines extent of disease
Diagnostic Procedures/Surgery
Skin testing: ‚
- Inject 0.1 mL of PPD intradermally in the forearm.
- Positive test indicates prior or current infection with M. tuberculosis.
- Test results are read between 48 and 72 hr after administration.
- Interpretation of positive: >5-mm induration:
- Close contacts with TB patients
- Positive chest radiographs for TB
- HIV-positive
- Organ transplant or other immunosuppression
- >10-mm induration:
- IV drug users
- Immigrants from high-prevalence countries (within 5 yr)
- Underlying disease (diabetes, renal failure, malignancies)
- Healthcare workers
- Prison inmates
- Institutionalized (nursing home, homeless shelters)
- >15-mm induration:
Differential Diagnosis
- Bacterial pneumonia
- Bronchiectasis
- Coccidiomycosis
- Histoplasmosis
- Lung abscess
- Lung carcinoma
- Lymphoma
- Pneumocystis carinii pneumonia
- Pulmonary embolism
- Sarcoidosis
Treatment
Pre-Hospital
- Place patient in respiratory isolation (negative flow).
- Place a mask on the patient to prevent respiratory spread of the disease.
- Initiate treatment with an IV, oxygen, and pulse oximetry.
- Endotracheal intubation may be required in patients with severe hemoptysis or respiratory compromise.
- Providers should wear submicron particulate filter masks (N-95 designation).
- Inform close contacts.
Initial Stabilization/Therapy
- ABCs:
- Control airway as needed.
- Administer oxygen as needed.
- Place on patient cardiac monitor and pulse oximetry.
- Establish IV access with 0.9% normal saline
- Isolate patients in negative pressure rooms with at least 6 air exchanges per hour.
- Protection for healthcare workers (N-95 masks)
Ed Treatment/Procedures
- Isolation and strict respiratory precautions
- Treatment is augmented due to increasing multidrug resistance.
- Any regimen must contain at least 2 drugs to which the TB bacillus is susceptible.
- CDC currently recommends initial therapy that includes 4 1st-line drugs.
- LTBI with normal chest x-ray given isoniazid (INH) for 9 mo or weekly combination of INH and rifapentine (RPT) for 12 wk.
- Consult infectious disease specialists when treating HIV patients on antiretroviral therapies.
- Add dexamethasone for TB meningitis.
- Surgical drainage for TB empyema may be necessary; consult thoracic surgeon.
- Directly observed therapy (DOT) may be necessary to ensure compliance in certain populations.
- Intermittent (biweekly) regimen may demonstrate higher patient compliance.
Medication
First Line
- INH: 5 mg/kg, max. 300 mg (peds: 10 " “15 mg/kg, max. 300 mg) PO/IM per day:
- Refractory seizures in overdose, treat with pyridoxine 5 g IV over 5 min or PO
- Caution with alcohol coingestion, hepatitis
- Rifampin (RIF): 10 mg/kg, max. 600 mg (peds: 10 " “20 mg/kg, max. 600 mg) PO/IV per day
- Pyrazinamide (PZA): 20 " “25 mg/kg/d max. 2 g (peds: 15 " “30 mg/kg/d) or:
- <55 kg: 1 g PO per day
- 56 " “75 kg: 1.5 g PO per day
- >75 kg: 2 g PO per day
- Not recommended in pregnancy
- Ethambutol (ETB): 15 " “20 mg/kg, max. 1,600 mg (peds: 15 " “30 mg/kg, max. 1 g) PO per day or up to TID
- Not recommended <13 yr old, requires visual testing
- RPT: 10 mg/kg, max. 900 mg (peds: Not recommended <12 yr old) PO once per week or 300 mg PO weekly for 10 " “14 kg, 450 mg PO weekly for 14.1 " “25 kg, 600 mg PO weekly for 25.1 " “32 kg, 750 mg PO weekly for 32.1 " “49.9 kg, 900 mg PO weekly for >50 kg
- Rifabutin: 5 mg/kg, max. 300 mg (peds: Unknown) PO per day
Second Line
(Less Effective, More Toxic)
- Streptomycin: 15 mg/kg/d, max. 1 g (peds: 20 " “40 mg/kg/d) IM/IV per day:
- Teratogenic: Contraindicated in pregnancy
- Ethionamide: 0.5 " “1 g (peds: 10 " “20 mg/kg/d) PO div. QID
- Levaquin: 750 mg (peds: Contraindicated) PO/IV per day
Follow-Up
Disposition
Admission Criteria
- Respiratory compromise
- Suspicion of diagnosis
- Inability to comply with outpatient therapy
- Unavailable outpatient resources (no PCP)
- Involuntary admission for noncompliant outpatients occurs:
- Be aware of respective state laws concerning involuntary admission (consult infectious disease specialist).
Discharge Criteria
- Without respiratory compromise
- Home isolation procedure compliance
- Ability and willingness to comply with long-term therapy
- Appropriate outpatient follow-up and treatment available
- Notification of the public health authorities is mandatory.
Issues for Referral
Referral to Department of Public Health for DOT ‚
Follow-Up Recommendations
- Sputum analysis periodically to document clearance
- Medication toxicity monitoring:
- INH, RIF, PZA: Monitor liver function tests for hepatitis
- PZA: Check uric acid levels
- ETB: Eye testing for color blindness
Pearls and Pitfalls
- Early isolation and respiratory precautions
- Careful history to establish risk factors
- The chest x-ray and PPD are great diagnostic aids.
- Initial 4-drug regimen for active disease
- Nonadherent, active TB patients are considered a public health hazard:
- Specific state laws are applicable in numerous areas.
Additional Reading
- American Thoracic Society; CDC; Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep. 2003;52(RR-11):1 " “77.
- American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Controlling tuberculosis in the United States. Am J Respir Crit Care Med. 2005;172:1169 " “1227.
- Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR. 2011;60(RR-48):1650 " “1653.
- Moran ‚ GJ, Talan ‚ DA.Tuberculosis. In: Wolfson ‚ AB, ed. Harwood-Nuss ' Clinical Practice ofEmergency Medicine. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins: 2010:912 " “917.
- Taylor ‚ Z, Nolan ‚ CM, Blumberg ‚ HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep. 2005;54(RR-12):1 " “81. http://www.cdc.gov/tb/publications/factsheets/statistics/TBTrends.html. Accessed on February 28, 2013.
See Also (Topic, Algorithm, Electronic Media Element)
- Pneumonia, Adult
- Bronchiectasis
- Coccidiomycosis
- Histoplasmosis
- Lymphoma
- Pneumocystis carinii Pneumonia
- Pulmonary Embolism
- Sarcoidosis
Codes
ICD9
- 010.90 Primary tuberculous infection, unspecified, unspecified
- 011.90 Unspecified pulmonary tuberculosis, unspecified
- 795.51 Nonspecific reaction to tuberculin skin test without active tuberculosis
- 018.90 Miliary tuberculosis, unspecified, unspecified
- 013.20 Tuberculoma of brain, unspecified
- 017.90 Tuberculosis of other specified organs, unspecified
ICD10
- A15.7 Primary respiratory tuberculosis
- A15.9 Respiratory tuberculosis unspecified
- R76.11 Nonspecific reaction to skin test w/o active tuberculosis
- A19.9 Miliary tuberculosis, unspecified
- A17.81 Tuberculoma of brain and spinal cord
- A18.84 Tuberculosis of heart
- A18.89 Tuberculosis of other sites
SNOMED
- 56717001 Tuberculosis (disorder)
- 63309002 Primary tuberculosis (disorder)
- 441846005 Nonspecific tuberculin test reaction (finding)
- 47604008 Miliary tuberculosis (disorder)
- 302131003 Tuberculosis of heart (disorder)
- 31112008 Tuberculous meningoencephalitis (disorder)